| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aspira Women's Health Inc. | Director | Common Stock | 496,129 | $1,671,955 | $3.37 | 31 Mar 2022 | Direct |
| Aspira Women's Health Inc. | Director | Employee Stock Option (Right to Buy) | 110,305 | $352,976 | $3.20 | 31 Mar 2022 | Direct |
| HTG MOLECULAR DIAGNOSTICS, INC | Director | Stock Option (right to buy) | 4,000 | 18 Aug 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AWHL | Aspira Women's Health Inc. | 31 Mar 2022 | 2 | $0 | 4 | Director | 04 Apr 2022, 20:23 |
| /report/000120919121052582-lafrance-james-t-2021-08-18 | HTG MOLECULAR DIAGNOSTICS, INC | 18 Aug 2021 | 1 | $0 | 4 | Director | 19 Aug 2021, 17:17 |
| AWHL | Aspira Women's Health Inc. | 24 Jun 2021 | 2 | $0 | 4 | Director | 16 Sep 2021, 18:14 |
| AWHL | Aspira Women's Health Inc. | 06 May 2021 | 2 | $0 | 4 | Director | 16 Sep 2021, 18:06 |